Metagenomics Market Analysis, Size, Growth, Share, Outlook & Forecast to 2027
The global metagenomics market size is expected to reach USD 1.40 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 16.6% during the forecast period. Rise in demand for microbial screening in food and chemical industries for commercial applications, coupled with rapid developments in bioinformatics and biotechnology tools, is anticipated to accelerate market growth in the coming years. Key market participants are striving to capitalize potential avenues in the market by addressing challenges faced by research entities pertaining to data assembly, identification, and verification of rare metagenomes. Furthermore, companies operating in the molecular diagnostics and genomics arena are a playing crucial role in this market by partnering with metagenomics companies for development of novel tests for disease diagnosis. For instance, in September 2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory-a metagenomic NGS test for screening of respiratory infections. The anticipated launch of many such novel tests is projected to boost the market during the forecast period. Metagenomics Market Report Highlights 
Kits and reagents formed the largest segment by product in 2017 owing to frequent usage at various steps in microbial genomic studies
Surplus growth in genomics database with respect to types and numbers has led to rising demand for better data analysis solutions. As a result, the sequencing and data analytics services segment is expected to emerge as a lucrative source of revenue generation during the forecast period
Function driven technology held the major revenue share in 2017. Development of new screening procedures that facilitate rapid screening of large clone libraries has enabledfunctional detection of novel enzymes from metagenomes
Browse Details of Report @ https://www.grandviewresearch.com/industryanalysis/metagenomics-market
Advancements in genetic tools have broadened the application scope of metagenomics to include targeting microbes responsible for inducing various cancer forms. This, in turn, is driving the application of metagenomic analysis in human health
North America dominated the market in 2017. Strong presence of key NGS leaders like Illumina and a substantial number of ongoing genomics-related studies in U.S. are major factors contributing to its large share
Some of the key competitors in the market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup
Acquisition of small players with a strong product portfolio is a prominently adopted strategy by dominant players. For instance, in August 2016, PerkinElmer acquired Bioo Scientific Corporationprovider of 16S & 18S library preparation kits for metagenome studies
Competitors are also involved in collaborations with bioinformatics companies for co-development of novel platforms for metagenomics analysis.
Metagenomics Market Segmentation Metagenomics Market Segmentation
Grand View Research has segmented the global metagenomics market on the basis of product, technology, application, and region: Metagenomics Product Outlook (Revenue, USD Million, 2014 - 2025)
Kits & Reagents
Sequencing & Data Analytics Services
Others
Metagenomics Technology Outlook (Revenue, USD Million, 2014 - 2025)
Sequencing Driven
Function Driven
Metagenomics Application Outlook (Revenue, USD Million, 2014 - 2025)
Environmental
Human Health
Others
Get Sample of Report @ https://www.grandviewresearch.com/industryanalysis/metagenomics-market/request/rs1 Metagenomics Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America o
U.S.
o
Canada
Europe o
Germany
o
U.K.
Asia Pacific o
Japan
o
China
Latin America o
Brazil
Middle East and Africa (MEA) o
South Africa
Table of Content Chapter 1 Executive Summary 1.1 Market Snapshot Chapter 2 Research Methodology 2.1 Information Procurement 2.1.1 Purchased database: 2.1.2 GVR’s internal database 2.2 Information or Data Analysis 2.3 Market Formulation & Validation 2.4 Approaches for Market Estimation 2.4.1 Approach 1: Commodity flow & bottom up approach 2.4.2 Approach 2: Top down and parent market analysis Chapter 3 Metagenomics Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.1.1 Market driver analysis 3.1.1.1 Declining expenses of sequencing
3.1.1.1.1 Decline in cost of per genome sequencing 2010 to 2016 3.1.1.1.2 Decline in cost of per Megabase DNA sequencing 2010 to 2016 3.1.1.2 Developments in biotechnology & bioinformatics techniques 3.1.1.3 Interest in microbial screening for different investigations 3.1.1.3.1 Number of metagenomics studies registered in Integrated Microbial Genomes & Microbiomes (IMG/M) web server 2017 3.1.1.4 Emergence of new fields in genomics that complement metagenomics 3.1.2 Market restraint analysis Continue‌‌‌ About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA
Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com